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Abstract
AIM: To investigate the clinicopathologic features which 
predict surgical overall survival in patients with proximal 
gastric carcinoma involving the esophagus (PGCE).
METHODS: Electronic pathology database established 
in the Department of Pathology of the Nanjing Drum 
Tower Hospital was searched for consecutive resection 
cases of proximal gastric carcinoma over the period 
from May 2004 through July 2009. Each retrieved pa-
thology report was reviewed and the cases with tumors 
crossing the gastroesophageal junction line were se-
lected as PGCE. Each tumor was re-staged, following 
the guidelines on esophageal adenocarcinoma, accord-
ing to the 7th edition of the American Joint Commission 
on Cancer Staging Manual. All histology slides were 
studied along with the pathology report for a retrospec-
tive analysis of 13 clinicopathologic features, i.e., age, 
gender, Helicobacter pylori (H. pylori) infection, surgical 
modality, Siewert type, tumor Bormann’s type, size, dif-
ferentiation, histology type, surgical margin, lympho-
vascular and perineural invasion, and pathologic stage 
in relation to survival after surgical resection. Prognos-
tic factors for overall survival were assessed with uni- 
and multi-variate analyses.
RESULTS: Patients’ mean age was 65 years (range: 
47-90 years). The male: female ratio was 3.3. The 1-, 3- 
and 5-year overall survival rates were 87%, 61% and 
32%, respectively. By univariate analysis, age, male 
gender, H. pylori, tumor Bormann’s type, size, histology 
type, surgical modality, positive surgical margin, lym-
phovascular invasion, and pT stage were not predictive 
for overall survival; in contrast, perineural invasion (P 
= 0.003), poor differentiation (P = 0.0003), > 15 to-
tal lymph nodes retrieved (P = 0.008), positive lymph 
nodes (P = 0.001), and distant metastasis (P = 0.005) 
predicted poor post-operative overall survival. Celiac 
axis nodal metastasis was associated with significantly 
worse overall survival (P = 0.007). By multivariate 
analysis, ≥ 16 positive nodes (P = 0.018), lymph node 
ratio > 0.2 (P = 0.003), and overall pathologic stage (P Zhang YF et al. Survival predictors of adenocarcinoma involving esophagus
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= 0.002) were independent predictors for poor overall 
survival after resection.
CONCLUSION: Patients with PGCE showed worse over-
all survival in elderly, high nodal burden and advanced 
pathologic stage. This cancer may be more accurately 
staged as gastric, than esophageal, cancer.
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
Carcinoma in the gastroesophageal junction (GEJ) region 
can be sub-grouped by the Siewert classification system 
into 3 types on the basis of the distance between tumor 
epicenter and the GEJ line
[1,2]. Type Ⅰ carcinomas are 
centered in the distal esophagus, 1-5 cm above the GEJ. 
They arise largely from Barrett’s esophagus (BE), may or 
may not invade the GEJ, and are commonly reported as 
Barrett’s adenocarcinoma. Type Ⅱ tumors straddle the 
GEJ line and are believed to be true GEJ cancers with 
epicenter within 1 cm above and 2 cm below the GEJ. 
Type Ⅲ tumors are sub-cardial gastric cancers with epi-
center 2-5 cm below the GEJ that is crossed as they grow 
proximally.
Although the Siewert classification system has been 
widely used internationally, its prognostic value has been 
challenged
[3-5]. In Asian countries, type Ⅰ GEJ cancer is 
rare and types Ⅱ and Ⅲ carcinomas behave similarly
[5,6]. 
In China, almost all GEJ carcinomas arise in the proximal 
stomach with a stable or slightly increased incidence in 
recent years
[7-10]. In our most recent study comparing clin-
icopathologic features of GEJ cancer between Chinese 
patients treated in Nanjing, China, and American patients 
treated in Boston, the United States, we showed that al-
most all GEJ cancers in Chinese patients were Siewert 
types Ⅱ and Ⅲ tumors
[11], unlike those seen in American 
patients in which the distribution of these three types 
of tumors was almost evenly
[12]. Their tumors were not 
BE-related, but associated with proximal gastritis with 
Helicobacter pylori (H. pylori) infection and a better overall 
survival rate, despite a larger tumor size and more ad-
vanced pathologic stages at diagnosis
[11]. Surprisingly, the 
studies on factors predicting post-operative overall sur-
vival in Chinese patients with proximal gastric carcinoma 
involving the esophagus (PGCE) are scarce. The purpose 
of the present study was to investigate clinicopathologic 
features that may predict overall survival after surgical re-
section in Chinese patients with PGCE who were treated 
at a single high-volume tertiary medical center in Nanjing, 
China.
MATERIALS AND METHODS
Selection of patients
A total of 177 consecutive resection cases of histopatho-
logically confirmed proximal gastric carcinoma were iden-
tified through a search of the computerized pathology 
database established in the Department of Pathology of 
the Nanjing Drum Tower Hospital in Nanjing, China, 
over the period from May 2004 through July 2009. Each 
pathology report was reviewed (by Huang Q) for cases 
with tumors crossing the GEJ line. Inclusion criteria 
were: (1) a tumor with epicenter in the proximal stomach 
within 5 cm below the GEJ and invading into the distal 
esophagus, which corresponded to Siewert types Ⅱ and 
Ⅲ tumors; (2) no chemotherapy or radiation therapy 
before the surgical resection; and (3) the availability of 
follow-up information through telephone interviews (by 
Feng AN) to the patient or family members. Exclusion 
criteria consisted of: (1) the tumor not crossing the GEJ; 
and (2) the patient lost to follow-up. Following a standard 
comprehensive surgical pathology processing protocol, 
all resection specimens were evaluated for the Bormann’s 
gross type and surgical margins. The GEJ line, defined by 
the proximal end of gastric longitudinal mucosal folds, 
was evaluated in each case. The tumor epicenter loca-
tion and its distance from the GEJ were recorded. The 
number of overall survival months after surgery was cal-
culated until May 2010, based on whether the patient was 
alive or had died of any cause. For all selected patients, 
medical records and pathology reports were re-evaluated 
for demographic and clinicopathologic information, tu-
mor stage, surgical approach (total or partial gastrectomy 
or Ivor-Lewis procedure), completeness of resection, and 
histopathology of the tumor. The study protocol was ap-
proved by the Medical Ethics Committee of the Nanjing 
Drum Tower Hospital in Nanjing, China.
Tumor staging 
All tumors were staged with the esophageal cancer staging 
criteria, according to the 7th edition of the American Joint 
Commission on Cancer Staging Manual (AJCC 7)
[13]. The 
status of regional involved lymph nodes in the para-distal 
esophageal, para-cardial and peri-gastric regions was de-
termined microscopically. The lymph nodes in the celiac 
axis region, including the left gastric artery, celiac artery, 
hepatic and splenic hila, etc., were identified by the surgeon 
during the operation, submitted as separate specimens 
and examined microscopically. Lymph node metastasis 
was determined by the routine histological examination. 
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and staged as esophageal cancer, metastases to celiac axis 
regional nodes were considered as distant metastasis
[13,14].
The proximal, distal and radial margins of resection 
were routinely inked for microscopic examination and 
classified as negative or positive if there was histological 
evidence of carcinoma present at, or within 1 mm of the 
inked resection edge. Lymphovascular and peri-neural in-
vasion was assessed microscopically on routine histology 
sections. Suspected distant tumor metastasis in the liver 
or other organs detected and biopsied intraoperatively 
was confirmed microscopically. 
Statistical analysis
All patients’ demographic and tumor gross characteris-
tics were considered categorical variables except for age, 
overall survival month, number of lymph nodes retrieved 
and number of lymph nodes involved, which were clas-
sified as continuous variables. All statistical analysis was 
carried out (by Shi J) using the SPSS software (SPSS Inc., 
version 15.0, Chicago, IL, United States). Specific com-
parison between groups was performed using χ
2 and 
Student t tests. Patient overall survival rates after surgical 
resection were estimated with the Kaplan-Meier method 
and the log rank test. The patients who were alive at the 
last follow-up were censored for calculation of the over-
all survival rates. Cox multivariate proportional hazards 
regression models were used to assess the overall survival 
power of these parameters. The P value of < 0.05 was 
considered statistically significant.
RESULTS
Clinicopathologic characteristics
A total of 142 cases were eligible for this study. The pa-
tients’ demographics, clinicopathologic characteristics, 
and the results of univariate overall survival analysis were 
shown in Table 1. Most (82%) tumors were type Ⅱ of 
the Siewert classification, while there was no type Ⅰ tumor 
in this cohort. The mean patient age was 65 years (range: 
47-90). The male-female ratio was 3.3. The number of 
months of patient follow-up after surgical resection was 
29 ± 17 mo (mean ± SD, range: 1-70 mo). By the time of 
the last follow-up, 58 (41%) patients had died and the re-
maining survivors were censored. Overall, the 1-, 3- and 
5-year overall survival rates were 87%, 61% and 36%, 
respectively. Among the demographic and pathologic 
variables, perineural invasion and poor tumor differentia-
tion were associated with worse overall survival (Table 1). 
None of the surgical modalities were found significant 
for overall survival prediction. The status of H. pylori   
infection, tumor gross type, gender, age, tumor size, lym-
phovascular invasion, and even positive surgical margins 
were not significant for overall survival prediction by uni-
variate analysis.
Pathologic staging 
Following the AJCC 7 staging guidelines, the vast majori-
ties (88%) of tumors were skewed to pT3 and only a few 
staged at pT1 (n = 4), pT2 (n = 12) and pT4 (n = 1). The 
pT stage was found not to be a relevant factor for overall 
survival prediction. In contrast, positive lymph node me-
tastasis were detected in 106 (75%) cases and significantly 
associated with worse overall survival (Table 2). Twelve 
of 142 patients (8%) had distant metastasis at the time of 
operation and showed significantly worse overall survival.
Lymph node status with overall survival
The mean number of lymph nodes retrieved per case was 
21 (range: 4-66). The presence of lymph node metastasis 
was found in 106 (75%) cases. There were 12 patients (8%) 
with cancer metastasis in celiac axis lymph nodes, which 
significantly predicted worse overall survival by univari-
ate analysis (Table 2). There was a statistically significant 
overall survival difference between patients with a total 
number of retrieved lymph nodes ≤ 15 and ≥ 16 (Table 
2). The numbers of positive lymph nodes more than 7 
and 16 were worse overall survival predictors. The ratio 
of the number of positive nodes to the total number of 
nodes retrieved, i.e., the lymph node ratio, was signifi-
cantly associated with worse overall survival (Tables 2 
and 3, Figure 1).
Significance of the lymph node ratio on overall survival
Among 3 different lymph node ratio groups, the lymph 
node ratios were significantly associated with the worse 
overall survival (Tables 2 and 3). The overall survival sta-
tus was better illustrated on a Kaplan-Meier plot among 
groups with lymph node ratios > 0.2, compared to that 
with the ratio ≤ 0.2 (Figure 1). We found that the relative 
risk for poor overall survival was 37-fold when the lymph 
node ratio was over 0.4 and 75-fold when over 0.5, com-
pared with the ratio at 0.
Independent factors predicting overall survival retained 
at multivariate analysis
By multivariate analysis, over 16 positive lymph nodes per 
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Figure 1  Kaplan-Meier overall survival curves of patients stratified by 
various lymph node ratios. The difference in overall survival among lymph 
node ratio (LNR) groups was statistically significant. 
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Table 1 Demographic, clinical, and pathological features predicting overall survival in patients with proximal gastric carcinoma in-
volving esophagus
Characteristics Number of patients 
(%) 
Months after surgery 
(mean ± SD)
P value 1-yr survival 
%
3-yr survival 
%
5-yr survival 
%
Age (yr)     0.108
   < 70 97 (68.3) 30 ± 17 91.1 65.3 40.1
   ≥ 70 45 (31.7) 27 ± 19 77.0 49.3 17.3
Gender     0.594
   Male               109 (76.8) 28 ± 17 71.1 61.1 23.1
   Female 33 (23.2) 30 ± 18 88.3 60.1 48.1
Helicobacter pylori infection     0.400
   Negative 80 (56.3) 30 ± 18 87.3 67.6 29.4
   Positive 62 (43.7) 27 ± 17 87.1 50.8 32.3
Surgical modality     0.950
   Partial gastrectomy               112 (78.9) 29 ± 18 85.7 68.6 35.1
   Total gastrectomy 21 (14.8) 28 ± 18 76.2 65.3  0.0
   Ivor-Lewis procedure 9 (6.3) 29 ± 17 89.2 60.6 34.3
Siewert type     0.444
   Type Ⅱ               116 (81.7) 29 ± 17 86.8 63.8 27.2
   Type Ⅲ 26 (18.3) 33 ± 19 88.5 50.2 40.2
Bormann’s type     0.380
   Polypoid 2 (1.4) 27 ± 26        100.0 50.1 50.1
   Fungating 17 (12.0) 34 ± 20 83.3 70.9 53.2
   Ulcerated 96 (67.6) 28 ± 17 88.0 56.3 26.8
   Flat 27 (19.0) 26 ± 18 86.5 66.6 29.6
Tumor size (cm)     0.087
   < 3 19 (13.4) 30 ± 17 87.0 72.1 17.2
   3.1-7.9 112 (78.9) 30 ± 17 89.7 61.5 38.5
   > 8 11 (7.7) 18 ± 15 63.6 26.5  0.0
Surgical margin     0.165
   Negative               126 (88.7) 30 ± 17 88.8 60.6 30.1
   Positive 16 (11.3) 23 ± 19 74.5 66.2 33.1
Lymphovascular invasion     0.050
   Negative 56 (39.4) 33 ± 18 90.9 65.6 31.2
   Positive 86 (60.6) 27 ± 17 84. 57.6 31.7
Perineural invasion     0.003
   Negative 55 (38.7) 35 ± 18 92.7 63.4 41.3
   Positive 87 (61.3) 26 ± 17 83.6 59.4 19.3
Tumor differentiation        0.0003
   Well 1 (0.7) 57        100.0        100.0         100.0
   Moderately 70 (49.3) 34 ± 17 95.2 69.3 44.2
   Poorly 70 (49.3) 24 ± 16 81.3 52.7 11.3
   Undifferentiated 1 (0.7) 4 0.0            0.0   0.0
Tumor histopathology     0.548
   Adenocarcinoma (nitric oxide synthase) 112 (78.9) 31 ± 17 89.6 71.0 34.2
   Adenocarcinoma with micropapillary feature 24 (16.9) 24 ± 10 100   0.0   0.0
   Adenosquamous carcinoma 9 (6.3) 28 ± 15 88.9 33.3   0.0
   Mucinous carcinoma 9 (6.3) 24 ± 14 88.9 30.5 30.5
   Signet ring cell carcinoma 23 (16.2) 23 ± 19 69.3 58.5 39.0
   Carcinoma with neuroendocrine features 7 (4.9) 28 ± 17        100.0 50.0 25.0
   Carcinoma with mixed types 37 (26.1) 24 ± 13 86.3 50.1 50.1
Pathologic T stage     0.400
   1A                   2 38 ± 27        100.0 50.0 50.0
   1B                   2                    47 ± 3        100.0        100.0         100.0
   2                 12 27 ± 17 83.3 72.9 54.7
   3               125 29 ± 17 87.0 59.8 29.2
   4A                   0 0 - - -
   4B                   1 18        100.0   0.0   0.0
Pathologic N stage     0.001
   0                 36 35 ± 17 94.4 72.0 53.5
   1                 22 32 ± 17 91.3 70.1 70.1
   2                 35 30 ± 17 85.3 64.7 15.9
   3A                 35 25 ± 17 85.3 57.4 14.4
   3B                 14 15 ± 9 70.7 41.3 10.3
Pathologic M stage     0.005
   M0               130 28 ± 18 88.3 64.5 32.5
   M1                 12                    12 ± 4 75.0 13.1 13.1
Overall stage     0.012
   1A                   4 42 ± 16        100.0 75.0 75.0
   1B                   7 30 ± 15        100.0        100.0         100.0
   2A                 26 34 ± 19 88.5 63.0 42.0
   2B                 26 32 ± 17 84.6 66.8 60.7
   3A                 29 31 ± 17 93.1 72.6 19.8
   3B                 29 27 ± 18 86.2 62.9 15.3
   3C                   9 18 ± 10 76.2 15.2 15.2
   4                 12                    16 ± 9 75.0 13.1 13.1
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case, lymph node ratio > 0.2, and the overall pathologic 
stage were found to be independent factors for predicting 
worse surgical overall survival (Table 3).
DISCUSSION
In this study, the factors predicting overall surgical sur-
vival in Chinese patients with PGCE are similar to those 
of gastric cancers but different from those of GEJ can-
cers reported in patients from Western countries
[15-18]. We 
show that in Chinese patients, type Ⅰ GEJ carcinomas 
remain vanishingly rare and PGCE tumors are mostly 
as type Ⅱ and some as type Ⅲ GEJ cancers. The fac-
tors predicting surgical overall survival are comparable 
to those reported in Japan
[6] and China Taiwan
[5]. Impor-
tantly, nodal burden in PGCE correlates highly with post-
operative overall survival, as seen in gastric cancer. Nodal 
metastasis in the celiac axis region is a significant predic-
tor of worse overall survival. Finally, the independent risk 
factors for worse overall survival in our patients include 
tumor metastasis in more than 16 nodes, the lymph node 
ratio > 0.2, distant metastasis, and overall pathologic 
stage; in contrast, the prognostic factors, such as > 70 
years, BE, the male gender, tumor histology type, the sur-
gical resection method, and even positive resection mar-
gin, etc., are not significant for predicting overall survival 
in Chinese patients with PGCE, which are predictive in 
type Ⅰ GEJ carcinomas in Western patients
[15,19], probably 
because of the rarity of the type Ⅰ GEJ carcinomas in 
Chinse patients. Our results would impact upon surgical 
management of Chinese patients with PGCE, if con-
firmed in a larger prospective trial(s).
Accurate GEJ cancer staging is difficult. The AJCC 7 
staging system requires the use of the esophageal scheme 
for pathologic staging of this group of cancers, regardless 
of the location of tumor epicenters. This new mandate 
is controversial. In a recent study, we showed that PGCE 
staged with the gastric cancer staging rules was better 
stratified, especially for the pN and pⅢ stages, compared 
to the use of the esophageal scheme that showed an er-
roneously better overall survival in the patients staged at 
pⅢA than those at pⅠA and pⅡB
[20]. The results shown 
in this study further substantiate the above conclusion 
and lent support to the contention that the current AJCC 
7 cancer staging system for GEJ cancer needs to be mod-
ified when applied to Chinese patients with PGCE.
Lymph node metastasis in gastric cancer has been 
shown to be more significant in predicting overall sur-
vival than tumor invasion depth.This concept was con-
firmed in this study. For instance, we found no significant 
differences in overall survival among patients with differ-
ent pT stages by either univariate or multivariate analysis. 
In contrast, the number of positive lymph nodes dictated 
patient overall survival
[16]. Furthermore, the total number 
of nodes retrieved (> 15) had a significant overall sur-
vival predictive value, as suggested by others
[17]. This may 
have resulted in a more precise evaluation of positive 
nodes and thus more accurate pN staging. In the current 
series, the overall survival was significantly worse in the 
patients with considerable nodal burden such as more 
than 7 positive nodes and higher lymph node ratios. Ap-
parently, a rich lymphatic network in the GEJ region, 
and/or protein lytic enzymes secreted by neoplastic cells, 
may facilitate the lymphatic dissemination of neoplastic 
cells to intra-abdominal nodes
[16,21]. It was reported that 
even for pT1b GEJ cancers, 30% of cases with positive 
Table 2  Univariate analysis of overall survival in patients with 
lymph node metastasis
Overall survival 
Characteristic No. of 
patients (%)
HR 95% CI
1 P value
Celiac axis lymph node
   Negative 130 (92) 1.00
   Positive 12 (8) 3.33 1.40 7.95 0.007
Perineural invasion
   Negative      55 (38.7) 1.00
   Positive      87 (61.3) 1.48 0.54 4.11 0.447
Number of nodes retrieved/case
   10   21 (15) 1.00
   ≥ 11 121 (85) 1.48 0.72 3.06 0.290
   ≤ 15   46 (32) 1.00
   ≥ 16   96 (68) 2.29 1.24 4.22 0.008
   ≤ 23 100 (70) 1.00
   ≥ 24   42 (30) 1.15 0.65 2.03 0.627
Number of positive nodes/case
   ≤ 6   58 (41) 1.00
   ≥ 7   48 (34) 1.72 1.20 2.46 0.003
   ≤ 15   92 (65) 1.00
   ≥ 16   14 (10) 2.30 1.40 3.77 0.001
Lymph node ratio
   0   36 (25) 1.00
   ≤ 0.2   40 (28) 1.34 0.61 2.97 0.467
   > 0.2   66 (46) 2.28 1.15 4.51 0.018
1Hazards ratios (HR), 95% confidence interval (CI) and P values for post-
operative time to recurrence and overall survival were adjusted according 
to important clinical characteristics. Survival time was defined as the pe-
riod from the surgical treatment to endpoint of follow-up.
Factor No. of 
patients
Multivariate analysis
HR 95% CI P value
Celiac axis lymph node  Compared to pN0
   Negative 130
   Positive   12 1.76 0.68 4.57 0.246
Number of positive nodes/case Compared to pN0
   LN
+ ≥ 7   48 1.34 0.6 2.96 0.467
   LN
+ ≥ 16    14 2.77 1.15 4.51 0.018
Lymph node ratio   Compared to pN0
   ≤ 0.2   40      3.8 1.28   11.26 0.016
   > 0.2   66 7.79 2.05   29.57 0.003
Overall stage pIV Compared to pI
  12    18.43 2.27 145.62 0.002
Tumor differentiation Compared to well differentiated
poorly differentiated   70 1.42 0.79 2.55 0.243
Table 3  Independent overall survival predictors retained by 
multivariate analysis
LN: Lymph node; HR: Hazards ratio; CI: Confidence interval.
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nodes had a 5-year overall survival rate of only 33%
[18]. 
Moreover, patients with primary tumors in the middle to 
lower esophagus and the proximal stomach were found 
to have nodal diseases within the abdomen at rates of 
as high as 45% to 93%
[22,23]. Taken together, our data 
emphasize the important overall survival predictive value 
for a thorough abdominal nodal dissection in Chinese 
patients with PGCE
[21].
The significance of the ratio between involved and 
retrieved lymph nodes for overall survival prediction has 
not been described in patients with PGCE. Our results 
add into a growing body of evidence for the value of a 
lymph node ratio in predicting overall survival of patients 
with PGCE. In the late 1990s, Siewert et al
[24] published 
their findings of prognostic significance of the lymph 
node ratio in gastric cancer in a large German cohort of 
1654 cases. Their conclusion was repeatedly confirmed by 
the studies in gastric cancer patients in Japan
[25,26], China 
Taiwan
[5], mainland China
[27,28], South Korea
[29], Spain
[30] 
and Italy
[31]. The advantage of the use of this parameter in 
patients with PGCE lies upon its ease to use, irrespective 
of the surgical methods used by different surgeons and 
various types of resection specimens from different pa-
tients
[24]. In reality, the number of retrieved lymph nodes 
is largely influenced by the extent of lymph node dissec-
tion by different surgeons, whose nodal dissection skills 
vary
[32,33]. It was reported that patients with a lymph node 
ratio smaller than 0.2 had a better overall survival rate
[33,34], 
which is also our experience. As the lymph node ratio 
increases, so is the increased relative risk of poor overall 
survival. Our data show that in patients with PGCE, the 
lymph node ratio could be used clinically as a powerful 
overall survival predictor.
The significance of metastatic nodal disease in the 
celiac axis region in patients with GEJ cancers for overall 
survival prediction remains obscure due to limited studies 
in the literature
[18,21]. When nodal metastasis is discovered 
in this region, some studies classify it as a pM1a disease 
of distal esophageal or GEJ cancers
[14], according to the 
6th AJCC cancer staging system. The overall survival pre-
dictive value of positive celiac lymph nodes in proximal 
gastric cancer stays controversial
[18,35-37]. It was reported 
that the patients with undetected celiac nodal disease at 
the time of surgical resection were subsequently found 
to have celiac nodal involvement with overall survival 
similar to that of patients with stage Ⅲ disease
[21]. In our 
previous
[28] and current studies on PGCE, nodal disease 
in the celiac axis region was also an important overall 
survival predictor by univariate analysis, which, however, 
did not reach a statistically significant level by multivariate 
analysis, probably due to the small sample size. Neverthe-
less, it appears that the site of nodal disease may be as 
important as the number of nodal metastasis in predict-
ing overall survival for patients with PGCE.
The major limitations of this study are several. First, 
the sample size of the current cohort was relatively small 
and most cancer cases were advanced and staged at pⅢ. 
There were only a few cases staged at pⅠ or pⅣ, which 
might have contributed to the lack of significance for the 
tumor pT stage in overall survival prediction. Second, the 
patient follow-up was carried out by telephone interview 
only. This might have invited inaccurate and biased re-
sults. At present, an accurate electronic patient medical 
record system has not been established in China and the 
government death record of citizens is not available to 
the public. Therefore, telephone interview has been the 
primary tool to collect the overall survival information. 
Finally, because of the retrospective nature of the study, 
the methods for surgical resection, lymph node retrieval, 
and specimen dissection were not standardized, which 
might have caused inconsistent nodal retrieval results. 
However, in over 75% of cases in this study, the number 
of lymph nodes retrieved per case was over 21. There-
fore, the overall data quality should be reasonably solid 
and reliable. 
In conclusions, PGCE, like gastric cancer, has simi-
lar overall survival after resection in patients with no or 
minimal nodal burden in this cohort of consecutively 
treated Chinese patients. However, the elderly patients 
over 70 years and those with considerable nodal diseases 
including celiac nodal metastasis, distant metastasis, and 
advanced summary pathologic stage fare worse in over-
all survival after resection. Application of the AJCC 7 
esophageal staging scheme to PGCE may be less accurate 
in predicting overall survival than applying the gastric 
staging scheme
[20]. Because of the small sample size and 
a single institution experience, further larger, prospective 
studies are required to validate our findings in the Chi-
nese patient population.
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GEJ cancers reported in patients from Western countries. The authors show 
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highly with post-operative overall survival, as seen in gastric cancer. Nodal 
metastasis in the celiac axis region is a significant predictor of worse overall 
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